1PM: https://globalmeet.webcasts.com/starthere.jsp?ei=1734135&tp_key=279919a01b
8PM: https://globalmeet.webcasts.com/starthere.jsp?ei=1734137&tp_key=880cf5b67e
Program Description
Using the results from biomarker testing to guide treatment selection is a critical step in non-small cell lung cancer (NSCLC) treatment. For oncology pharmacists, understanding how to interpret these results ensures that patients receive the most appropriate, safe, and effective biomarker-directed therapies. Building on the foundation established in the first webinar in this series, "Precision Matters: Foundations of Biomarker-Driven Care in NSCLC," this second webinar will offer oncology pharmacists additional guidance on how to navigate the complexities of biomarker testing and its application in clinical practice. The activity will cover testing pearls, including the logistical challenges of sending samples for testing and the clinical significance of accurately interpreting test results. Real-world implications of precision medicine testing in NSCLC will be discussed, with a focus on addressing common barriers to precision medicine implementation in oncology settings to offer pharmacists potential solutions to overcome these hurdles. By the end of this webinar, oncology pharmacists will be better equipped to advocate for appropriate biomarker testing, interpret complex results, and take on an expanded role in delivering targeted therapies to patients with NSCLC.
Target audience: Oncology pharmacists
Type of activity: Application
Release date: October 9, 2025
Expiration date: December 9, 2025
Time to complete activity: 1.0 hours
Learner level: Intermediate
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Explain the importance of biomarker testing to drive therapeutic selection
- Determine strategies to address and overcome challenges in biomarker testing
- Examine the evolving role of pharmacists in biomarker-guided therapy and precision medicine
Mya Tran, PharmD, BCOP
Precision Oncology Clinical Pharmacist
Indiana University Health – Simon Comprehensive Cancer Center
Indianapolis, Indiana
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hours (0.10 CEU) under the ACPE universal activity number 0290-0000-25-297-L01-P. The activity is available for CE credit through December 9, 2025.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
Mya Tran, PharmD, BCOP, has the following relevant financial relationships with ineligible companies to disclose:
Advisory board: Johnson and Johnson
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Amy L. Morris, PharmD; Crissy Wilson; Susan Pordon; Brianna Winters and Chloe Taccetta have no financial relationships with ineligible companies to disclose.
All of the relevant financial relationships listed for these individuals have been mitigated.
At least one anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with ineligible companies to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms